ZDA
NPSP

Zweig-DiMenna Associates’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Zweig-DiMenna Associates’s Portfolio NPSP Stock Details NPSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-259,356
Closed -$7.76M – 325
2014
Q1 		$7.76M Buy
259,356
+74,356
+40% +$2.56M 0.46% 77
2013
Q4 		$5.62M Buy
+185,000
New +$5.1M 0.21% 114

Other funds holding NPSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Zweig-DiMenna Associates's NPSP Position: Q2 2014 in Review

Zweig-DiMenna Associates sold out of NPS PHARMACEUTICALS INC (NPSP) in Q2 2014, closing a stake of 259,356 shares — an estimated $7.76M sold.

Zweig-DiMenna Associates first reported a position in NPSP in Q4 2013 and held it in 2 quarters. The position peaked at $7.76M in Q1 2014. 215 funds tracked by Wall St. Rank hold NPSP as of Q2 2014.

  • Zweig-DiMenna Associates reported no remaining NPS PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Zweig-DiMenna Associates sold 259,356 NPS PHARMACEUTICALS INC shares in Q2 2014, an estimated $7.76M.
  • Zweig-DiMenna Associates first reported a position in NPS PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Zweig-DiMenna Associates's NPS PHARMACEUTICALS INC position peaked at $7.76M in Q1 2014.
  • 215 funds tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q2 2014.

Based on Zweig-DiMenna Associates's 13F filing for Q2 2014, filed 12 Aug 2014.